Skip to Main content Skip to Navigation
Journal articles

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Ron T. Gansevoort 1 Mustafa Arici 2 Thomas Benzing 3, 4 Henrik Birn 5, 6 Giovambattista Capasso Adrian Covic 7 Olivier Devuyst 8, 9, 10 Christiane Drechsler 11 Kai-Uwe Eckardt 12 Francesco Emma 13 Bertrand Knebelmann 14 Yannick Le Meur 15, 16 Ziad A. Massy 17, 18, 19 Albert C.M. Ong 20 Alberto Ortiz 21, 22, 23 Franz Schaefer 24 Roser Torra 25, 26 Raymond Vanholder 27 Andrzej Więcek 25, 28 Carmine Zoccali 29 Wim van Biesen 30
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-brest.fr/hal-01267538
Contributor : Geneviève Michel <>
Submitted on : Thursday, February 4, 2016 - 3:23:24 PM
Last modification on : Wednesday, September 16, 2020 - 5:10:42 PM

Links full text

Identifiers

Citation

Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, et al.. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2015, ⟨10.1093/ndt/gfv456⟩. ⟨hal-01267538⟩

Share

Metrics